Research progress of probiotics intervening osteoporosis through intestinal tract
10.3760/cma.j.cn431274-20220827-00851
- VernacularTitle:益生菌通过肠道干预骨质疏松症的研究进展
- Author:
Pu GAO
1
;
Hao YIN
;
Xuejun HE
Author Information
1. 湖南省人民医院（湖南师范大学附属第一医院）骨五科，长沙 410005
- Keywords:
Osteoporosis;
Probiotics;
Intestinal flora;
Estrogen
- From:
Journal of Chinese Physician
2023;25(3):468-472
- CountryChina
- Language:Chinese
-
Abstract:
Osteoporosis (OP) is a systemic bone disease characterized by decreased bone density and damage to bone microstructure, leading to brittle fractures. It is a multifactorial disease that is more common in postmenopausal women, and its high incidence and serious complications are receiving increasing attention. Currently, clinical anti-osteoporosis drugs are mainly divided into two categories: inhibiting bone resorption and promoting bone formation, including bisphosphonates, calcitonin and estrogen, etc. But the side effects and high economic cost of drugs limit the scope of their use to some extent. In recent years, the effect of intestinal flora on bone health, especially on osteoporosis, has become a potential new target for regulating bone density. Probiotics belong to intestinal flora and are defined as living microorganisms. They have initially shown good efficacy in the treatment of some bone metabolic diseases, suggesting that intestinal flora can be used as a potential target for the prevention and treatment of osteoporosis and the application of probiotics as a new therapeutic method for osteoporosis. This paper mainly reviews the relevant studies on probiotics and osteoporosis, shows the latest research progress of probiotics intervention in OP, clarifies the relevant action mechanism of probiotics intervention in OP through intestinal tract, and analyzes the research status and prospect of probiotics treatment in OP.
